Return to Prescription Drug Watch

October 7, 2006

Merck's Cancer Drug Zolinza Approved

The FDA has approved Zolinza, Merck's first new cancer drug in about 20 years. The drug has been approved to treat cutaneous T-cell lymphoma, a rare form of non-Hodgkin's lymphoma.

While the market as a treatment for the cancer, also called CTCL, is limited, Merck is studying the drug as a tumor-fighting treatment in many other cancers, including of the breast and lung. Additional approvals from the FDA could vastly expand the market for the drug, also known as vorinostat.

Merck cancer drug approved

Posted by Staff at 8:35 PM | Comments (1)


Prescription Drug Watch is part of the
Health Diaries network. Health Diaries publishes blogs, articles, and news on health and fitness topics.


get well cards
Tell someone you're thinking of them with one of our free get well cards. We also have sympathy cards and blank cards if you want to send thanks or just a hello.

Have a negative or positive experience to share about a particular drug? Drop us a line at drugwatch @ (remove the spaces).
All content published on is provided for informational and educational purposes only. does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.

Copyright © 2004-2007 and the authors. All rights reserved.
(function (tos) { window.setInterval(function () { tos = (function (t) { return t[0] == 50 ? (parseInt(t[1]) + 1) + ':00' : (t[1] || '0') + ':' + (parseInt(t[0]) + 10); })(tos.split(':').reverse()); window.pageTracker ? pageTracker._trackEvent('Time', 'Log', tos) : _gaq.push(['_trackEvent', 'Time', 'Log', tos]); }, 10000); })('00');